Desvenlafaxine
NDC 10135-822, Desvenlafaxine, tablet, extended release, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-822
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204805
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESVENLAFAXINE SUCCINATE100 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-822-10 | 10135082210 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-10) |
| 10135-822-14 | 10135082214 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-14) |
| 10135-822-30 | 10135082230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-30) |
| 10135-822-90 | 10135082290 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/387cea91-6924-2a68-e063-6394a90a8f75
Use it
Look up 10135-822 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.